Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy.

被引：0
|
作者：
Hovind, P
Tarnow, L
Rossing, P
Carstensen, B
Parving, HH
机构：
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[2] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus C, Denmark
来源：
DIABETOLOGIA | 2003年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
85
引用
收藏
页码：A32 / A32
页数：1
相关论文
共 50 条
  • [41] Increased serum hepatocyte growth factor (HGF) in patients with diabetic nephropathy.
    Shikano, M
    Sobajima, H
    Kushimoto, H
    Katsumata, H
    Murakami, K
    Hasegawa, M
    Tomita, M
    Hasegawa, H
    Kawashima, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0561 - A0561
  • [42] Polymorphism of the angiotensin converting enzyme (ACE) gene in patients with diabetic nephropathy.
    SemetkowskaJurkiewicz, E
    Nowakowski, M
    Bigda, J
    Pawlowski, R
    Narkiewicz, K
    Bieniaszewski, L
    Chrostowska, M
    KrupaWojciechowska, B
    DIABETOLOGIA, 1997, 40 : 2049 - 2049
  • [43] Abnormalities of glucose metabolism in parents of IDDM-patients with diabetic nephropathy.
    Groop, PH
    Fagerudd, J
    PetterssonFernholm, K
    GronhagenRiska, C
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0564 - A0564
  • [44] Impact of clinical remission by steroid pulse therapy and tonsillectomy on pregnancy in patients with IgA nephropathy.
    Sato, M
    Hotta, O
    Taguma, Y
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 766A - 766A
  • [45] Circulating mitochondrial DNA content is associated with albuminuria in patients with diabetic nephropathy
    Malik, A. N.
    Landau, S.
    Gnudi, L.
    DIABETIC MEDICINE, 2013, 30 : 71 - 71
  • [46] Adding spironolactone to conventional antihypertensives reduces albuminuria in patients with diabetic nephropathy
    Murray Epstein
    Nature Clinical Practice Nephrology, 2006, 2 : 310 - 311
  • [47] Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen, S
    Tarnow, L
    Rossing, P
    Hansen, BV
    Parving, HH
    DIABETOLOGIA, 1999, 42 : A10 - A10
  • [48] Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy A Randomized Clinical Trial
    Bakris, George L.
    Agarwal, Rajiv
    Chan, Juliana C.
    Cooper, Mark E.
    Gansevoort, Ron T.
    Haller, Hermann
    Remuzzi, Giuseppe
    Rossing, Peter
    Schmieder, Roland E.
    Nowack, Christina
    Kolkhof, Peter
    Joseph, Amer
    Pieper, Alexander
    Kimmeskamp-Kirschbaum, Nina
    Ruilope, Luis M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (09): : 884 - 894
  • [49] Increased albumin excretion rate in non-diabetic offspring of NIDDM patients with diabetic nephropathy.
    Forsblom, C
    Saloranta, C
    Karanko, S
    Groop, L
    DIABETOLOGIA, 1997, 40 : 65 - 65
  • [50] Cardiovascular outcomes in the irbesartan diabetic nephropathy trial (IDNT) of patients with type 2 diabetes and overt nephropathy.
    Berl, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 651A - 651A
12345